This medical marijuana start-up uses artificial intelligence to find which strain is best for you
It was founded by father and son David and Baruch Goldstein. Baruch previously worked on AI technology to help find botanical treatments for pre-Alzheimer’s patients.
Potbot uses AI to “read” through peer-reviewed medical journals to find studies on cannabinoids, the active compounds in marijuana. Using the research, it pairs 37 symptoms like insomnia, asthma and cancer with branded marijuana strains to find which type of weed is best suited to treat each one.
The company has raised $5 million to date, according to Potbotics CEO David Goldstein.
Read More at CNBC.com